Previous close | 7.72 |
Open | 9.74 |
Bid | 9.35 x 200 |
Ask | 9.40 x 200 |
Day's range | 8.85 - 9.98 |
52-week range | 7.11 - 14.84 |
Volume | |
Avg. volume | 592,604 |
Market cap | 364.055M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.60 |
Earnings date | 31 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 16.20 |
Amidst robust sales growth and operational enhancements, Pulmonx Corp (LUNG) demonstrates a strong start to 2024 with significant improvements in revenue and gross margins.
Pulmonx (LUNG) delivered earnings and revenue surprises of 16.28% and 7.52%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?